Gabelli Funds’s Niagen Bioscience NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$947K Buy
214,685
+10,685
+5% +$57.7K 0.01% 909
2025
Q4
$1.3M Buy
204,000
+16,500
+9% +$115K 0.01% 848
2025
Q3
$1.75M Sell
187,500
-2,400
-1% -$24.2K 0.01% 791
2025
Q2
$2.74M Sell
189,900
-14,900
-7% -$147K 0.02% 661
2025
Q1
$1.41M Buy
204,800
+14,800
+8% +$93K 0.01% 715
2024
Q4
$1.01M Sell
190,000
-10,000
-5% -$54.7K 0.01% 783
2024
Q3
$730K Hold
200,000
0.01% 841
2024
Q2
$546K Hold
200,000
﹤0.01% 883
2024
Q1
$696K Hold
200,000
0.01% 845
2023
Q4
$286K Buy
200,000
+20,000
+11% +$27.9K ﹤0.01% 960
2023
Q3
$263K Buy
180,000
+15,000
+9% +$23.4K ﹤0.01% 984
2023
Q2
$259K Buy
165,000
+8,200
+5% +$12.2K ﹤0.01% 990
2023
Q1
$240K Buy
156,800
+104,800
+202% +$187K ﹤0.01% 1017
2022
Q4
$87.4K Buy
52,000
+24,000
+86% +$38.1K ﹤0.01% 1112
2022
Q3
$34K Buy
+28,000
New +$45.1K ﹤0.01% 1227

Other funds holding NAGE